U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Wednesday.
Shares of Dynavax Technologies Corp (NASDAQ: DVAX ) rose sharply during Wednesday's session after Sanofi SA (NASDAQ: SNY ) agreed to acquire the company for $15.50 per share in cash, reflecting a total equity value of approximately $2.2 billion.
The acquisition augments Sanofi's presence in adult immunization.
Dynavax shares jumped 38.6% to $15.44 on Wednesday.
Here are some other big stocks recording gains in today’s session.
Omeros Corp (NASDAQ: OMER ) shares jumped 66.8% to $14.60 after the FDA approved YARTEMLEA to treat hematopoietic stem cell transplant–associated thrombotic microangiopathy. Edgewise Therapeutics Inc (NASDAQ: EWTX ) gained 23.8% to $26.94. Edgewise Therapeutics on Wednesday shared updates from the ongoing CIRRUS-HCM Phase 2 trial of EDG-7500. Agios Pharmaceuticals Inc (NASDAQ: AGIO ) surged 17.9% to $29.00 after the company announced the FDA approved AQVESME for the treatment of anemia in adults with alpha- or beta-thalassemia. An exect announced AQVESME will be introduce at approximately $425,000 per patient per year. Wheels Up Experience Inc (NYSE: UP ) gained 14.8% to $0.73. Travere Therapeutics Inc (NASDAQ: TVTX ) gained 14.3% to $40.41. Coincheck Group NV (NASDAQ: CNCK ) surged 12.5% to $2.88. Polestar Automotive Holding Uk Plc (NASDAQ: PSNY ) jumped 11.8% to $16.92. Polestar Automotive recently announced a $300 million equity investment from Banco Bilbao Vizcaya Argentaria and Natixis. CapsoVision Inc (NYSE: CV ) gained 11.6% to $14.39. X4 Pharmaceuticals Inc (NASDAQ: XFOR ) gained 9.5% to $4.52. Falcon’s Beyond Global Inc (NASDAQ: FBYD ) jumped 9.4% to $18.35. Falcon’s Beyond Global recently announced filing of a $100 million mixed shelf offering. BIOAGE Labs Inc (NASDAQ: BIOA ) jumped 8.8% to $14.37. Kodiak Sciences Inc (NASDAQ: KOD ) gained 8.6% to $29.81. UiPath Inc (NYSE: PATH ) jumped 7.9% to $17.23 after it was announced that it will replace Synovus Financial in the S&P MidCap 400. Immuneering Corp (NASDAQ: IMRX ) rose 6.8% to $6.83. Immuneering announced that it would provide an update on 12-month overall survival from its ongoing Phase 2a clinical trial of atebimetinib + mGnP in first-line pancreatic cancer patients, on January 7, 2026. Nike Inc (NYSE: NKE ) gained 4.7% to $60.03 as investors weighed a notable insider purchase against ongoing concerns around tariffs, China demand, and a slower-than-expected turnaround. Micron Technology Inc (NASDAQ: MU ) gained 3.5% to $286.01.Read This Next:
How To Earn $500 A Month From Meta StockPhoto via Shutterstock
AGIO Agios Pharmaceuticals Inc $29.30 19.2% Overview BIOA Bioage Labs Inc $14.34 8.55% CNCK Coincheck Group NV $2.88 12.5% CV CapsoVision Inc $14.73 14.2% DVAX Dynavax Technologies Corp $15.44 38.7% EWTX Edgewise Therapeutics Inc $27.04 24.4% FBYD Falcons Beyond Global Inc $18.35 9.42% IMRX Immuneering Corp $6.82 6.73% KOD Kodiak Sciences Inc $29.77 8.45% MU Micron Technology Inc $287.22 3.96% NKE Nike Inc $60.18 4.95% OMER Omeros Corp $14.91 70.4% PATH UiPath Inc $17.18 7.61% PSNY Polestar Automotive Holding UK PLC $16.99 12.3% SNY Sanofi SA $48.41 0.19% TVTX Travere Therapeutics Inc $40.59 14.8% UP Wheels Up Experience Inc $0.7267 15.4% XFOR X4 Pharmaceuticals Inc $4.53 9.95% Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Add CommentPosted In: News Markets Movers Trading Ideas big gainers